We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 25th:
Eton Pharmaceuticals, Inc. (ETON - Free Report) : This specialty pharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.6% over the last 60 days.
Okta, Inc. (OKTA - Free Report) : This identity solutions company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 62% over the last 60 days.
Vizsla Silver Corp. (VZLA - Free Report) : This explorer and developer of precious and base metal assets has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.3% over the last 60 days.
Image: Bigstock
Best Momentum Stocks to Buy for January 25th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 25th:
Eton Pharmaceuticals, Inc. (ETON - Free Report) : This specialty pharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.6% over the last 60 days.
Eton Pharmaceuticals, Inc. Price and Consensus
Eton Pharmaceuticals, Inc. price-consensus-chart | Eton Pharmaceuticals, Inc. Quote
Eton’s shares gained 51.5% over the last three months compared with the S&P 500’s advance of 4.7%. The company possesses a Momentum Score of A.
Eton Pharmaceuticals, Inc. Price
Eton Pharmaceuticals, Inc. price | Eton Pharmaceuticals, Inc. Quote
Okta, Inc. (OKTA - Free Report) : This identity solutions company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 62% over the last 60 days.
Okta, Inc. Price and Consensus
Okta, Inc. price-consensus-chart | Okta, Inc. Quote
Okta’s shares gained 20.6% over the last three months compared with the S&P 500’s advance of 4.7%. The company possesses a Momentum Score of A.
Okta, Inc. Price
Okta, Inc. price | Okta, Inc. Quote
Vizsla Silver Corp. (VZLA - Free Report) : This explorer and developer of precious and base metal assets has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.3% over the last 60 days.
Vizsla Silver Corp. Price and Consensus
Vizsla Silver Corp. price-consensus-chart | Vizsla Silver Corp. Quote
Vizsla’s shares gained 11% over the last three months compared with the S&P 500’s advance of 4.7%. The company possesses a Momentum Score of B.
Vizsla Silver Corp. Price
Vizsla Silver Corp. price | Vizsla Silver Corp. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.